⏳ Fetching live dividend data...
Home › Calculator › SYN Dividend Calculator 2026
Synthetic Biologics, Inc. · AMEX
Price: $1.02 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in SYN → $46.4K in 10 years · $7.39/month
Synthetic Biologics, Inc. is a clinical-stage biotechnology firm focused on creating treatments for illnesses with significant unmet medical demands. Among its leading product candidates is SYN-004, engineered to neutralize common intravenous beta-lactam antibiotics within the digestive system. This aims to safeguard the gut microbiome, prevent Clostridium difficile infections (CDI), curb the proliferation of harmful bacteria, combat antimicrobial resistance (AMR), and mitigate acute graft-versus-host-disease (aGVHD) in patients undergoing allogeneic hematopoietic cell transplants. Another key asset is SYN-020, an orally administered recombinant formulation of intestinal alkaline phosphatase, intended to address both localized gastrointestinal and systemic conditions. The company is also advancing VCN-01, a therapeutic candidate for various cancers, including pancreatic cancer, head and neck squamous cell carcinoma, colorectal cancer, and retinoblastoma. Additional clinical-stage programs include SYN-006, targeting the prevention of aGVHD and infections from carbapenem-resistant enterococci; SYN-007, designed to avert antibiotic-associated diarrhea linked to oral beta-lactam antibiotics; SYN-005, for the prevention and treatment of whooping cough (pertussis); and VCN-11, another cancer therapeutic. Synthetic Biologics maintains partnerships with Intrexon Corporation, The University of Texas at Austin, and Cedars-Sinai Medical Center. Furthermore, a clinical trial agreement with Washington University School of Medicine in St. Louis supports a Phase 1b/2a clinical trial for SYN-004. The company's main operations are based in Rockville, Maryland.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open SYN position with:
Real after-tax yield depends on where you live and how you hold SYN.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 196.08% | 193.28% | $19,608 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 166.67% | 163.87% | $16,667 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 156.86% | 154.06% | $15,686 / yr |
| 🇬🇧 UK ISA | 0% | 196.08% | 193.28% | $19,608 / yr |
| 🇬🇧 UK Taxable | 8.75% | 178.92% | 176.12% | $17,892 / yr |
| 🇨🇦 TFSA | 0% | 196.08% | 193.28% | $19,608 / yr |
| 🇨🇦 CA Taxable | 25% | 147.06% | 144.26% | $14,706 / yr |
| 🇦🇺 Super (pension) | 15% | 166.67% | 163.87% | $16,667 / yr |
| 🇦🇺 AU Taxable | 30% | 137.26% | 134.46% | $13,726 / yr |
| 🇩🇪 DE Taxable | 26.375% | 144.36% | 141.56% | $14,436 / yr |
| 🇫🇷 FR Taxable | 30% | 137.26% | 134.46% | $13,726 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
SYN pays quarterly — 4 times per year. Next ex-div: TBD.
How SYN compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for SYN sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2023-12-14 | 700,000 | $0.59 | $411.3K | ||
| A-Award | 2023-12-14 | 110,000 | $0.59 | $64.6K | ||
| A-Award | 2023-12-14 | 110,000 | $0.59 | $64.6K | ||
| A-Award | 2023-12-14 | 110,000 | $0.59 | $64.6K | ||
| Buy | 2023-06-07 | 14,000 | $0.69 | $9.7K | ||
| Buy | 2023-06-06 | 26,000 | $0.63 | $16.5K | ||
| Buy | 2023-02-10 | 25,000 | $1.04 | $26.1K | ||
| Buy | 2023-02-02 | 25,000 | $0.94 | $23.5K | ||
| Buy | 2023-01-25 | 25,000 | $0.87 | $21.8K | ||
| Buy | 2023-01-20 | 25,000 | $0.75 | $18.7K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the SYN dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Synthetic Biologics, Inc. (SYN) is currently trading at $1.02, trading near its 52-week low. The current dividend yield is 196.08% based on an annual payout of $2.00 per share.
Synthetic Biologics, Inc. (SYN) is a healthcare stock currently trading at $1.02 with a dividend yield of 196.08%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, SYN has grown its dividend at a compound annual rate of 50.0%.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever